Proof-of-mechanism has been established for TNG260 based on pharmacodynamic data from on-treatment patient biopsies, with ...

To get Belinda home, the Doctor takes the Vindicator to Lagos, Nigeria, to piggyback on the country’s communications network.

SG&A Expenses: Selling, general and administrative expenses were $29.3 million for the first quarter of 2025 compared to ...

Data update from ongoing TNG462 Phase 1/2 monotherapy trial expected 2H 2025 - - Combination trial of TNG462 + Revolution Medicines RAS(ON) inhibitors on track for enrollment 2Q 2025 - - Cash position ...

Third, the severe clinical outcomes and EMA orphan disease designation support ... At the upcoming EASL Congress, we'll be presenting a poster showcasing data from a 24-week subgroup analysis ...

And it’s evolving in a way that highly, that really benefits our focus in these patients ... led to the award of rare pediatric disease and orphan drug status for the treatment of epidermolysis ...

OJEMDA (tovorafenib) prescriptions grew 16% in Q1 2025 compared to Q4 2024 Achieved Q1 2025 OJEMDA (tovorafenib) net product revenue of $30.5 million Ended the first quarter with $473.0 million in cas ...

It’s all done via Steve Albini’s Closet where you can by books, LPs, CDs, posters, t-shirts, flyers, zines, posters/flyers, “mysterious bargains,” and more from his collection. Here’s ...

Marvel Studios recently rebranded Thunderbolts* as "The New Avengers," with a number of posters and billboards released displaying the new team name. Though it was somewhat surprising that the ...

PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies ...

The face painting was a hit at Zoey’s Place Carnival in 2024. This year’s benefit event is May 17. Submitted photo GREENFIELD — A carnival benefiting a local organization is coming up.

“It may be a directional benefit to used cars. And it may be a benefit to business models that are able to offer value to consumers, which is a business model that we think we fit in that box ...